Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

OTHER 3NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 313Thoracic 244Genitourinary 229Gastrointestinal 199Head & Neck 165Gynecologic 46Sarcoma 29Other solid neoplasm 19Tumor-Agnostic 17Dermatologic 8CNS 8Endocrine 3Other 2Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Thyroid Carcinoma, Anaplastic 1Neoplasms 1Carcinoma, Neuroendocrine 1Adrenocortical Carcinoma 1

Interventions

lutetium Lu 177 dotatate 36Everolimus 32pembrolizumab 24Temozolomide 21Magnetic Resonance Spectroscopy 21Nivolumab 18lenvatinib 17gallium Ga 68 dotatate 16cabozantinib 15Cisplatin 15lanreotide 143-Iodobenzylguanidine 14Capecitabine 13trametinib 12dabrafenib 12Bevacizumab 12Octreotide 11Surveys and Questionnaires 10Surgical Procedures, Operative 10Sunitinib 10Radiosurgery 10Positron Emission Tomography Computed Tomography 10Blood Specimen Collection 10Sorafenib 9Paclitaxel 9Ipilimumab 9Carboplatin 9surufatinib 8Etoposide 8Doxorubicin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Docetaxel × Endocrine × Clear all
NCT03837977 2024-12-30

NET02

The Christie NHS Foundation Trust

Phase 2 Completed
58 enrolled
Endocrine

Neoplasms, Carcinoma, Neuroendocrine

NCT03211117 2020-03-25

Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer

Mayo Clinic

Phase 2 Completed
3 enrolled 7 charts
EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT00324012 2012-02-22

Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma

Rigshospitalet, Denmark

Phase 2 Completed
19 enrolled
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡